After malaria, some immune cells long treated as exhausted may actually be moving through a carefully ordered life cycle. The surprising part is that cells from different beginnings can end up in the same late state. B cells help make antibodies, remember past threats, and regulate immune responses.

A group called atypical B cells became associated with disease and was first described as exhausted because of altered features and reduced responsiveness. Atypical B cells are now recognized as a dynamic population with marker expression and functions that vary depending on context.

Evidence indicates that atypical B cells are varied, which may explain their different functions. Their origins, relationships, and paths of change have remained poorly defined, causing conflicting interpretations. The study found that atypical B cells form one gradual continuum, with distinct memory and outside-the-usual tissue origins converging on a shared late state and changing functions along the way.

One route moved from inexperienced B cells through ordinary memory stages and intermediate atypical cells toward late atypical cells, reflecting progressively later stages. A second route passed through switched memory cells and ended in early atypical cells, especially influenced by one antibody class.

These routes may reflect different immune jobs or origins, but they do not prove a single straight chain of direct changes. Here is the everyday picture: think of a workplace with employees moving through early, middle, and late roles. These immune cells also occupied early, late, and two intermediate stages, identified by changing surface signals and internal activity.

The balance shifted with infection status: early cells were more common in healthy donors, while late cells were more common in people with malaria. The intermediate groups were transition states from different beginnings.

One came from memory cells formed in organized immune tissues, while the other came from memory cells resembling those found at the edges of immune tissues. Both of these routes eventually converged into the late atypical state.

The cells also changed jobs as they moved along the path. Early stages retained the ability to become antibody-producing cells and release immune signals, while late stages gained features linked to handling particles and displaying targets to other immune cells. These functional results supported the broader framework linking the cells' changing surface signals with their stage of development.

Across people with malaria and healthy donors, the stages showed gradual changes in internal activity, surface features, and function. The cells came from switched and unswitched memory cells formed in organized immune tissues, and from memory cells resembling those at immune-tissue edges.

Two surface signals helped separate the intermediate stages and connected stage with the ability to become antibody-secreting cells. That ability diminished in later groups under one type of immune stimulation. Malaria served as a model of inflammation that begins and then resolves, but the conclusions are meant to describe broader principles of atypical B-cell change, not malaria alone.

The analysis covered the wider pool of responding B cells rather than cells directly identified as targeting malaria, so the paths and functions describe the overall activated immune-cell group during infection. These cells are not one mysterious, fixed group: they form a gradual path, with different origins and changing jobs.

That map could help researchers interpret immune responses more clearly across infections.